Vimal Singh Munda

Vimal Singh Munda

Auto-generated profile, based on publicly available information

Vimal Singh Munda

Department of Microbiology, All India Institute of Medical Sciences, Deoghar, Jharkhand, 814152, India

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2017 in IOSR Journal of Dental and Medical Sciences
Verified
Journal Article
Closed access
LTLuguram Tudu
Luguram Tudu
VMVimal Singh Munda
Vimal Singh Munda
SHShamim Haider
Shamim Haider
VKVivek ` Kashyap
Vivek ` Kashyap

8 February 2021 in Current Respiratory Medicine Reviews
Verified
Journal Article
Closed access
PDF file
SKSaurabh Kumar
Saurabh Kumar
SKSandeep Kumar
Sandeep Kumar
AKAdil Karim
Adil Karim
KBKamlesh Bisht
Kamlesh Bisht
AGAbdul Ghani
Abdul Ghani
VMVimal Singh Munda
Vimal Singh Munda
Novel coronavirus-2019 (nCoV-2019) emerged as a potentially infectious respiratory disease caused by newly discovered β-coronavirus. nCoV-19 has emerged as a global pandemic due to the rapid transmission and high infection rate commonly involved in acute respiratory illness. Literature search includes various databases like Google Scholar, PubMed, ScienceDirect, and Scopus for studies published using a different combination of keywords “coronavius”, “COVID-19”, “SARS”, “MERS”, “antiviral drugs”, “vaccines”, and “immunity”. We collected epidemiology data from the Worldometer portal (data available till 9 October, 2020). Fever, dry cough, dyspnea, sore throat, or fatigue are common clinical symptoms of the infection. Cytotoxic T-cells and T-helper cells plus Cytotoxic T cells (CD8+) account for maximum (approximately 80%) of total infiltrate in the pulmonary region of the affected nCoV individuals and act as a significant contributor to the clearance of the infection. This review intends to outline the literature concerning the mode of actual transmission, immune response, and possible therapeutic approach against the virus.

1 June 2017 in IOSR Journal of Dental and Medical Sciences
Verified
Journal Article
Closed access
PSPadmaja Singh
Padmaja Singh
LTLuguram Tudu
Luguram Tudu
VMVimal Singh Munda
Vimal Singh Munda
RKRakesh Kumar
Rakesh Kumar

16 July 2026 in Infectious Disorders - Drug Targets
Verified
Journal Article
Closed access
PDF file
NSNeha Sharad
Neha Sharad
SKSupriya Kumari
Supriya Kumari
VMVimal Singh Munda
Vimal Singh Munda
PGPratima Gupta
Pratima Gupta
Introduction: Saprochaete capitata is a rare opportunistic yeast-like fungus increasingly recognized as a cause of invasive infections, predominantly in immunocompromised hosts. While most cases are reported in patients with hematological malignancies and neutropenia, infections in patients with chronic metabolic and renal disorders are uncommon and often underdiagnosed. Isolation of S. capitata from urine is particularly rare and poses diagnostic challenges in distinguishing colonization from invasive disease. Case Presentation: We report a fatal case of sepsis associated with Saprochaete capitata isolated from the urine of a 65-year-old male with type 2 diabetes mellitus, chronic kidney disease, and chronic lymphatic filariasis. The patient presented with fever, chills, tachycardia, cellulitis of the right lower limb, and features of systemic inflammatory response syndrome. Laboratory investigations revealed marked leukocytosis, elevated inflammatory markers, and acute-on-chronic renal failure. Despite clinical features of sepsis, repeated bacterial blood and urine cultures were sterile. Urine microscopy showed pyuria, and culture on CLED agar yielded dry, creamy-white, yeast-like colonies. A lactophenol cotton blue mount demonstrated hyaline septate hyphae with rectangular arthroconidia. The isolate was urease-negative and was definitively identified as Saprochaete capitata by MALDI-TOF mass spectrometry. Antifungal susceptibility testing revealed low minimum inhibitory concentrations (MICs) for voriconazole, itraconazole, and posaconazole, with elevated MICs for echinocandins, consistent with known resistance patterns. The patient was treated empirically with broad-spectrum antibacterial agents but did not receive early antifungal therapy. His clinical condition rapidly deteriorated, progressing to septic shock and multi-organ dysfunction syndrome, requiring intensive care support, mechanical ventilation, vasopressors, and hemodialysis. Despite maximal supportive care, the patient succumbed to his illness. Conclusion: This case highlights the clinical significance of isolating Saprochaete capitata from urine in high-risk patients presenting with sepsis and negative bacterial cultures. It underscores the need for heightened clinical suspicion, prompt fungal identification using advanced diagnostic methods, and early initiation of appropriate antifungal therapy. Awareness of this rare but aggressive pathogen is crucial for improving outcomes in vulnerable patient populations.